1-4 of 4
Anlai Wang
Close
Sort by
Journal Articles

CD38 Protects Tumor Cells from NK Lysis

Anlai Wang, MA, Guang Yang, MA, Zhili L Song, MSc, Francisco J Adrian, PhD
Journal: Blood
Blood (2015) 126 (23): 5389.
https://doi.org/10.1182/blood.V126.23.5389.5389
Published: 2015
Journal Articles

PIM inhibitors target CD25-positive AML cells through concomitant suppression of STAT5 activation and degradation of MYC oncogene

Zhuyan Guo, Anlai Wang, Weidong Zhang, Mikhail Levit, Qiang Gao, Claude Barberis, Michel Tabart, Jingxin Zhang, Dietmar Hoffmann, Dmitri Wiederschain, Jennifer Rocnik, Fangxian Sun, Josh Murtie, Christoph Lengauer, Stefan Gross, Bailin Zhang, Hong Cheng, Vinod Patel, Laurent Schio, Francisco Adrian, Marion Dorsch, Carlos Garcia-Echeverria, Shih-Min A. Huang
Journal: Blood
Blood (2014) 124 (11): 1777–1789.
https://doi.org/10.1182/blood-2014-01-551234
Published: 2014
Includes: Supplemental data
Journal Articles

Recombinant human interleukin-11 synergizes with steel factor and interleukin-3 to promote directly the early stages of murine megakaryocyte development in vitro

Nadine S. Weich, Michael Fitzgerald, Anlai Wang, James Calvetti, Joanne Yetz-Aldape, Steven Neben, Katherine J. Turner
Journal: Blood
Blood (2000) 95 (2): 503–509.
https://doi.org/10.1182/blood.V95.2.503
Published: 2000
Journal Articles

Recombinant Human Interleukin-11 Directly Promotes Megakaryocytopoiesis In Vitro

Nadine S. Weich, Anlai Wang, Michael Fitzgerald, Tamlyn Yee Neben, Debra Donaldson, JoAnn Giannotti, Joanne Yetz-Aldape, Robert M. Leven, Katherine J. Turner
Journal: Blood
Blood (1997) 90 (10): 3893–3902.
https://doi.org/10.1182/blood.V90.10.3893
Published: 1997